KALV
NASDAQ
$27
KalVista Pharmaceuticals Inc (KALV)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$1.38B
Free Cash Flow Yield
-4.74%
Price Chart
Valuation
Market Cap$1.38B
Forward P/E25.45
Profitability
Total Revenue (TTM)$56M
Gross Profit (TTM)$58M
EBITDA-$182M
Profit Margin-57.5%
Operating Margin-57.4%
EPS-$3.61
Financial Health
Debt-to-Equity-876.3%
Free Cash Flow Yield-4.74%
Growth & Risk
EPS 5Y CAGR+11.29%
FCF 5Y CAGR+16.60%
Sharpe Ratio1.25